Akebia Therapeutics and Satsuma Pharmaceuticals could both be big winners for early shareholders....…
CAMBRIDGE, Mass. , April 2, 2020 /PRNewswire/ -- Akebia Therapeutics …
Investors need to pay close attention to Akebia Therapeutics (AKBA) stock based on the movements in the options market lately....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
The biotech provided a disappointing Q4 update....…
AKBA earnings call for the period ending December 31, 2019....…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of -35.56% and -27.09%, respectively, for the quarter ended December 2019. Do…
Akebia Therapeutics (AKBA) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…
Investors need to pay close attention to Akebia Therapeutics (AKBA) stock based on the movements in the options market lately....…
Shares of Akebia Therapeutics Inc. (AKBA), which touched a new 52-week high of $10.42 in intraday trading yesterday, have gained…